Long-Awaited CLIA Draft Guidance Offers Some Leeway For Study Design
This article was originally published in The Pink Sheet Daily
Executive SummaryFDA draft offers flexibility for manufacturers to select comparative methods for clinical studies designed to show that tests are accurate. The Clinical Laboratory Improvement Advisory Committee meets Sept. 7-8 in Atlanta.
You may also be interested in...
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?
The commissioner says he will step down next month, leaving a legacy of active policy development, but also a lot of initiatives and pilot projects that are in the middle of being implemented.